| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |